Skip to content
2000
Volume 9, Issue 2
  • ISSN: 1574-3624
  • E-ISSN: 2212-389X

Abstract

Signal transduction has been acknowledged to be involved in various cell biological processes. And it is proved that multiple signaling pathways have been associated with the development and progression of pancreatic cancer, which remains one of the most devastating human diseases. Newly developed drugs targeting these aberrant signaling pathways show bright prospect in improving the therapeutic efficacy and outcome for patients with pancreatic cancer. Here we overview the pancreatic cancer related signaling pathway disorders and the corresponding promising targeted therapeutic regimens.

Loading

Article metrics loading...

/content/journals/cst/10.2174/1574362409666141201205149
2014-08-01
2025-12-17
Loading full text...

Full text loading...

/content/journals/cst/10.2174/1574362409666141201205149
Loading

  • Article Type:
    Research Article
Keyword(s): Pancreatic cancer; signal transduction pathway; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test